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Abstract  
Background: Clinical recommendations to limit gestational weight gain (GWG) imply high 
GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of 
several inter-related complex phenotypes (maternal fat deposition and vascular expansion, 
placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG 
could help clarify the potential effect of its different components on maternal and offspring 
health. Here we explore the genetic contribution to total, early and late GWG. 
Participants and Methods: A genome-wide association study was used to identify maternal 
and fetal variants contributing to GWG in up to 10,543 mothers and 16,317 offspring of 
European origin, with replication in 10,660 mothers and 7,561 offspring. Additional analyses 
determined the proportion of variability in GWG from maternal and fetal common genetic 
variants and the overlap of established genome-wide significant variants for phenotypes 
relevant to GWG (e.g. maternal BMI and glucose, birthweight). 
Results: Approximately 20% of the variability in GWG was tagged by common maternal 
genetic variants, and the fetal genome made a surprisingly minor contribution to explaining 
variation in GWG. Variants near the Pregnancy Specific Beta-1-Glycoprotein 5 (PSG5) gene 
reached genome-wide significance (P=1.71x10
-8
) for total GWG in the offspring genome, but 
did not replicate.  Some established variants associated with increased BMI, fasting glucose 
and type 2 diabetes were associated with lower early, and higher later GWG. Maternal 
variants related to higher systolic blood pressure were related to lower late GWG. Established 
maternal and fetal birthweight variants were largely unrelated to GWG.  
Conclusion: We found a modest contribution of maternal common variants to GWG and 
some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These 
findings suggest that associations between GWG and later offspring/maternal outcomes may 
be due to the relationship of maternal BMI and diabetes with GWG. 
©    2017 Macmillan Publishers Limited. All rights reserved.
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Introduction 
High and low levels of gestational weight gain (GWG), defined as the weight a woman gains 
during pregnancy before delivery of her infant,(1) are associated with a wide range of adverse 
outcomes for mother and child in the short- (during pregnancy and the perinatal period), and 
longer-term. (2-9) As a consequence of these associations, recommendations for healthy 
GWG are increasingly used in antenatal care,(1) despite a lack of evidence that any of these 
associations are causal, and if they are, what the mechanisms underlying them might be.(3, 
10) GWG is a complex phenotype that is influenced by maternal responses to pregnancy, 
such as gestational fat deposition and volume expansion, as well as fetal growth, placental 
size and amniotic fluid volume.(3, 10) Each of these are likely to be influenced both by 
maternal and fetal genes and environmental exposures. Understanding the maternal and fetal 
genetic contributions to GWG could shed light on both genetic and non-genetic contributions 
to between woman variation in GWG.(11, 12) For example, we have recently used maternal 
genetic instrumental variables to determine the causal effect of maternal pregnancy adiposity 
and related traits on offspring birthweight and ponderal index.(13)  
 
Amongst 1,159 European origin Swedish maternal twin pairs (694 pairs with data on their 
first pregnancies and 465 on their second) it has been shown that approximately 40% of 
variability in first pregnancy GWG was due to genetic factors.(14) Other studies have 
examined the associations of candidate maternal and/or fetal adiposity or diabetes related 
genetic variants with GWG and yielded inconsistent results; however these studies have had 
small sample sizes, been conducted in single studies and have not sought independent 
replication.(15-17) To our knowledge, no previous genome-wide association study (GWAS) 
of GWG has been conducted.  
 
©    2017 Macmillan Publishers Limited. All rights reserved.
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The aim of this study was to increase understanding of the genetic and non-genetic 
determinants of GWG by (a) estimating the proportion of variation in total, early and late 
GWG tagged by maternal and fetal common genetic variants; (b) undertaking a GWAS of 
maternal and fetal genetic variants with total, early and late GWG, and attempting to replicate 
associations in independent samples, and (c) determining the associations of genetic variants 
from GWAS of phenotypes that are plausible contributors to GWG (i.e. birthweight, BMI, 
waist-hip ratio, height, blood pressure, glucose, type 2 diabetes and vitamin D) with total, 
early and late GWG. We examined associations of maternal and fetal genetic exposures with 
total, early and late GWG, because the relative contribution of maternal and fetal phenotypes 
to GWG vary across gestation. For example, maternal fat deposition contributes relatively 
more to early GWG (up to ~ 18-20 weeks of gestation), and fetal growth more to later 
GWG.(3, 10) We included vitamin D (25(OH)D) as a phenotype that plausibly contributes to 
GWG as maternal 25(OH)D may have a positive affect on birthweight,(13) and therefore may 
have a positive association with GWG.  
 
Participants and Methods 
We included singleton pregnancies of mother-offspring pairs of European origin from 20 
pregnancy/birth cohorts, described in detail in eSupplementary material and eTable 1. 
Pregnancies that resulted in a miscarriage or stillbirth, those with a known congenital 
anomaly and those where delivery was preterm (before 37 completed weeks of gestation) 
were excluded.  
 
Total GWG was defined as the last gestational weight (as long as this was ≥ 28 weeks of 
gestation) before delivery minus pre-/early-pregnancy weight divided by the length of 
gestation in weeks at the last measurement. Pre/early-pregnancy weight was defined as 
©    2017 Macmillan Publishers Limited. All rights reserved.
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maternal self-reported pre-pregnancy weight (with this report collected during pregnancy), a 
research/clinical measure of weight prior to pregnancy (with that measure taken no more than 
12-weeks before predicted date of conception), or the first antenatal clinic weight (with that 
assessment ≤ 13 weeks of gestation), which ever was the earliest. Early GWG was the 
difference between pre-/early-pregnancy weight and weight measured any time between 18 
and 20 (inclusive) completed weeks of gestation divided by length of gestation in weeks at 
the time of the 18 to 20 week measurement. Late GWG was the difference between the 18 to 
20 week measurement and the last gestational weight measure at ≥ 28 weeks of gestation 
divided by the gestational age difference in completed weeks between these two 
measurements. Whilst we were interested in the possibility that different maternal and fetal 
genetic variants might contribute to early and late GWG (as discussed in the final paragraph 
of the introduction), we considered total GWG to be our main outcome. The rationale for this 
was: (a) this was the phenotype for which we had most data and therefore greatest statistical 
power; (b) the majority of epidemiological studies relating GWG to subsequent maternal and 
offspring outcomes use total GWG(2, 3, 7, 18); and (c) recommendations regarding optimal 
GWG use total GWG.(1) Similarly, the gestational ages used to define early and late GWG 
were based several factors: (a) maximising sample sizes for both early and late GWG which 
for many studies reflected times in pregnancy when women are routinely weighed; (b) 
evidence that the relative (to maternal contribution) fetal contribution to GWG becomes 
greater from 16-20 weeks of gestation(1, 19); and (c) applying multilevel models to the very 
detailed repeat measurements of gestational weight in the Avon Longitudinal Study of 
Parents and Children (ALSPAC), in which the median (IQR) of measurements per woman 
was 12 (9 to 13), demonstrated changes in the amount of weight gained per week of gestation 
at 18 and 28 weeks.(4, 20, 21) Other epidemiological studies report differences in GWG from 
around 14-15 weeks of pregnancy, but as discussed in previous reviews, this if often driven 
©    2017 Macmillan Publishers Limited. All rights reserved.
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by selecting measures around traditional trimesters (14 weeks being the time at which the 
second trimester begins.(1, 2) In studies with repeated measurements between 18 and 20 
weeks the one nearest to 18 weeks was used and in those with repeated later measurements 
the last weight was defined as the one nearest to (but before) delivery. Total, early and late 
GWG standard deviation (z-) scores were calculated within each study as the participant 
value minus the individual study mean then divided by the study standard deviation. 
 
Proportion of variation in total, early and late GWG, and birthweight that is due to 
maternal and fetal common genetic variants 
We used methods that have been developed for use with genome-wide data to estimate the 
proportion of variation in total, early and late GWG, and birthweight tagged by maternal and 
fetal common genetic variants. Genetic restricted maximum likelihood (GREML)(22) and 
maternal- genome-wide complex trait analysis (M-GCTA)(23) were applied to maternal and 
fetal genome-wide data from ALSPAC. The M-GCTA model uses similarity between 
mothers and offspring in the genome-wide data to partition the phenotypic variance in GWG 
into components due to the maternal genotype, the child’s genotype, the covariance between 
the maternal and child’s genotype and an environmental component.  
 
ALSPAC is a prospective population-based birth cohort study that recruited 14,541 pregnant 
women resident in Avon, UK with expected dates of delivery between 1
st
 April 1991 and 31
st
 
December 1992 (http://www.alspac.bris.ac.uk.).(24, 25) GWG was determined using data 
extracted from obstetric medical records by trained research midwives.(5) Birthweight, 
gestational age (in completed weeks) and fetal sex were obtained from obstetric/perinatal 
records. Maternal genome-wide data were obtained from the genome-wide Illumina 610 
Quad Array. Fetal genome-wide data were obtained from the genome-wide Illumina 550 
©    2017 Macmillan Publishers Limited. All rights reserved.
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Quad Array. Further details, including genotype imputation and QC are provided in online 
eSupplementary material and characteristics of the participants are described in eTable 1. 
 
Maternal and fetal GWAS of total, early and late GWG 
All studies in the Early Growth Genetics (EGG) consortium (http://egg-consortium.org/) with 
relevant data participated. Twenty independent pregnancy/birth cohorts contributed to at least 
one discovery and/or replication analysis (this included data from ALSPAC). Details of each 
of these studies are provided in eSupplementary Material and study participant 
characteristics, including their contribution to each GWAS, are shown in eTable 1. For total 
GWG, up to 10,543 (participants from ALSPAC, DNBC-GOYA, DNBC-PTB and MoBa; 
see eSupplementary material for details of these cohorts) and 16,317 participants (from 
ALSPAC, DNBC-PTB, Generation R, INMA, LISAplus, MoBa, NFBC-1966, PANIC, 
Raine, STRIP and TEENAGE; eSupplementary material) contributed to maternal and fetal 
discovery GWAS, respectively (eTable 1 and Table 1). The numbers for early and late GWG 
GWAS being somewhat lower (Table 1). Up to an additional 10,660 and 7,561 participants 
contributed to maternal and fetal replication samples (see eTable 1 for cohorts included), with 
the maximum total meta-analysis sample size for total GWG being 18,420 and 21,105 for 
maternal and fetal GWAS, respectively. 
 
All genotyping was undertaken by laboratory staff at each of the contributing studies who 
were blind to any phenotypic data. GWAS discovery and replication analyses were 
undertaken independently by analysts working with each of the contributing studies 
following a prior agreed analysis plan. Genotypic data imputed to HapMap Phase 2 (Build 
36, release 22) was used (methods for imputing within each contributing study is described in 
©    2017 Macmillan Publishers Limited. All rights reserved.
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the eSupplementary Material) in the analysis, assuming an additive genetic model and 
adjusting for fetal sex. 
 
Fixed-effects, inverse-variance weighted (IVW) meta-analyses in METAL(26) were 
undertaken to combine GWAS results from the individual discovery studies. The most 
significant SNPs in regions reaching suggestive significance (P<10
-5
) in the discovery GWAS 
of any of the analyses (i.e. total, early or late GWG or in the maternal or fetal genome) were 
taken forward to replication. This set of SNPs were analysed against the three phenotypes in 
the replication studies and the results were combined using IVW meta-analysis in R (version 
3.0.0) using the rmeta package.(27) Additionally, to investigate whether this set of top SNPs 
were more likely to be acting in the maternal or offspring genome to influence GWG, 
conditional analysis was conducted in studies where both maternal and fetal genotype were 
available. Again, the results from these analyses were combined using IVW meta-analysis in 
R (version 3.0.0). Computer code for the discovery and replication meta-analyses is available 
from the first author upon request. 
 
Maternal and fetal genetic variants for phenotypes with plausible contributions to GWG  
We examined the associations of a set of a priori agreed genetic variants that had previously 
(in GWAS) been shown to be robustly associated with phenotypes that might plausibly 
influence GWG with our GWG phenotypes. These were genetic variants for birthweight, 
BMI, waist-hip ratio, height, blood pressure, fasting glucose, type 2 diabetes and vitamin D 
(25(OH)D). eTable 2 lists the variants included for each of the traits. The results for each of 
the variants were extracted from the discovery GWAS, and the replication studies provided 
results for the subset of variants they had available. IVW meta-analysis was conducted in 
©    2017 Macmillan Publishers Limited. All rights reserved.
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METAL (26) to combine the results across all the cohorts.  In these hypothesis driven 
analyses we use a two-sided p-value of < 0.05 as indicating statistical significance. 
 
Results 
Total GWG was between 0.35 and 0.45kg/week in all of the general population studies and 
somewhat lower in the two studies that combined severely obese women with lean or a 
population cohort comparison group; in all studies early GWG was considerably lower than 
late GWG (eTable 1). The correlation between early (defined as between pre-pregnancy and 
18 weeks) and late GWG (18 to delivery) and between early and total GWG, in one of the 
largest contributing studies with data on both periods (ALSPAC) were -0.08 and -0.11, 
respectively. 
 
Proportion of variation in GWG and birthweight due to maternal and fetal common 
genetic variants 
SNPs across the genome explained broadly similar proportions of variation in late GWG and 
early GWG, but with stronger contributions of maternal compared with fetal genome, with 
SNPs in the maternal genome explaining approximately twice the amount of variation in total 
GWG than the fetal genome (Table 2). The opposite pattern was seen for birthweight, for 
example, SNPs across the maternal genome explained 24% (P = 1.94x10
-6
) of the variation in 
total GWG, with 12% (P = 0.008) explained by SNPs in the fetal genome, whereas the 
maternal genome explained 13% (P=0.02) and fetal genome 18% (P= 1.86x10
-3
) of variation 
in birthweight (Table 2). When we modelled maternal and fetal contributions together this 
pattern remained, but with the differences between maternal and fetal contributions 
increasing somewhat; for total GWG 17% and 5%, respectively for maternal and fetal 
genome and for birthweight 4% and 24%, respectively for maternal and fetal genome, with 
©    2017 Macmillan Publishers Limited. All rights reserved.
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relatively little covariance between the two genomes for either trait. When the covariance and 
offspring/maternal variance components were constrained to zero in the M-GCTA model, 
similar results to the GREML analysis were obtained (eTable 3). 
 
Maternal and fetal GWAS of total, early and late GWG 
There was no systematic inflation of the test statistics in the meta-analysis of approximately 
2.5 million SNPs (λmat-early=1.01, λmat-late=1.01, λmat-total=1.02, λoff-early=1.02, λoff-late=1.00, λoff-
total=1.00; eFigure 1). In discovery analyses, one variant, rs16989175 near the pregnancy 
specific beta 1-glycoprotein 5 (PSG5) gene, reached conventional GWAS significance 
(<5x10
-8
) for fetal genetic association with total GWG; it also showed some evidence of fetal 
association with late (p = 2.4 × 10
-3
) and early (p = 0.02) GWG. However, it did not replicate 
in either the maternal or fetal analysis. An additional 9 regions were identified as being 
suggestively significant (p < 10
-5
) for at least one phenotype in either maternal or fetal 
genome (eFigure 2). These were taken forward in replication analyses. Only one of these 10 
SNPs replicated, rs310087 near SYT4 (Table 1). This SNP was associated with total GWG in 
the fetal genome (mean difference in total GWG per allele 0.06 (95%CI: 0.04, 0.08) kg/week; 
p = 3×10
-6
 in discovery samples and 0.05 (95%CI: 0.01, 0.09) kg/week; p = 0.03 in 
replication samples and 0.06 (95%CI: 0.04, 0.08) kg/week; p = 1.6×10
-5
 in pooled discovery 
and replication). For six out of the ten top SNPs identified (rs481396, rs3924699, rs6457375, 
rs13295979, rs1702200 and rs7133083), the point estimate was larger for the maternal 
genotype on total GWG than the offspring genotype on this phenotype (Table 1). This was 
suggested in conditional analyses, whereby the point estimates for the offspring genotypes 
mostly attenuated after adjusting for maternal genotype (Table 3). The variant near SYT4 that 
in the fetal genome was nominally significantly associated with total GWG in discovery 
analyses and replicated, was not notably altered with adjustment for the maternal variant. 
©    2017 Macmillan Publishers Limited. All rights reserved.
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Summary statistics from the discovery meta-analyses are available at http://egg-
consortium.org/. 
 
Association of maternal and fetal genotypes for phenotypes with plausible contributions 
with GWG 
Seven of the 32 BMI associated SNPs showed evidence of association (p < 0.05) with early 
GWG using maternal genotype, with five of the BMI increasing alleles associated with a 
decrease in early GWG (eFigure 3). In contrast, only three of the BMI associated SNPs 
showed association with late GWG using maternal genotype, and all three increased both 
BMI and GWG. A similar pattern of association was seen with the SNPs associated with 
glucose (eFigure 4) and type 2 diabetes (eFigure 5), whereby alleles associated with 
increased glucose/risk of type 2 diabetes showed evidence of association of maternal 
genotype with decreased GWG in early gestation and with increased GWG in late gestation. 
A smaller portion of SNPs for these phenotypes using the offspring genotype were associated 
with GWG (eFigures 3 to 5).  
 
Surprisingly, none of the birthweight associated SNPs using the offspring genotype were 
associated with any GWG phenotype (eFigure 6). However, the SNP with the largest effect 
on birthweight (from fetal GWAS of birthweight), rs900400, using the maternal genotype 
was associated with decreased late GWG and total GWG, for each birthweight increasing 
SNP. SNPs associated with blood pressure, when using the maternal genome, showed 
stronger association with late GWG than early GWG, with the blood pressure increasing 
allele for most variants associating with decreased GWG (eFigure 7). Offspring blood 
pressure SNPs and SNPs associated with waist-hip ratio (maternal or offspring; eFigure 8), 
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vitamin D (25(OH)D) (eFigure 9) or height (eFigure 10) were not notably associated with 
any GWG phenotypes. 
  
Discussion 
We have shown that approximately 20% of the variability in GWG can be explained by 
common maternal genetic variants. A much smaller contribution is made by common genetic 
variants from the fetal genome. This pattern of maternal and fetal genetic contribution is 
opposite to what we see with birthweight, for which the fetal contribution is greater. Despite 
this modest genetic contribution, which is similar to the common genetic contribution to 
birthweight and many other phenotypes,(28) in what we believe to be the first genome-wide 
association study of GWG, we were unable to identify any genetic variants that reached 
genome-wide levels of significance (P<5x10
-8
) and that replicated. Given the possible 
contribution of several adiposity related phenotypes to overall GWG, we also investigated 
whether genetic variants that are known to be associated with these traits were also associated 
with GWG. Some maternal BMI, fasting glucose and type 2 diabetes variants were nominally 
associated with GWG, such that those that were associated with increased BMI, glucose or 
type 2 diabetes, were associated with lower early and higher late GWG. Some maternal 
variants associated with higher systolic blood pressure also associated with lower late GWG. 
In general fetal variants associated with these traits were largely unrelated to GWG. Of note, 
established maternal and fetal birthweight variants were for the most part not related to 
GWG. The one exception being rs900400, a variant previously shown to be strongly related 
to birthweight in a genome-wide study of fetal genotype,(29) which in our study was 
inversely associated with late and total GWG in the case of the maternal genotype. This 
variant has also been recently shown to be inversely associated with leptin in genome-wide 
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analyses,(30) and thus the inverse association of this variant in the mother with GWG may 
reflect a positive association of maternal leptin with GWG. 
 
Using a twin study, Andersson et al show that the heritability of first pregnancy GWG is 
43%;(14) we were able to show that approximately half of this could be explained by 
common genetic variants or variants they tag in the maternal genome. This is similar to the 
proportion of heritability explained in other common traits such as height and BMI.(28) It is 
perhaps not surprising that our results suggest that the maternal genome has a greater 
contribution to GWG than the offspring genome. On average, approximately 55% of GWG is 
a result of increased maternal tissue, 15-20% is due to the placenta and amniotic fluid, and 
20-25% is a result of fetal tissue.(19) The maternal genome will contribute to tissue 
expansion in the mother, as well as to placental size, amniotic fluid and fetal growth, 
whereas, it is likely that the fetal genome will only contribute to placenta, amniotic fluid and 
fetal growth. We detected some evidence of a negative genetic covariance in the M-GCTA 
analysis of late GWG. A negative covariance implies that a proportion of maternal genetic 
variants associated with increased GWG are associated with decreased GWG when present in 
the fetal genome. Although this was a surprising result, it is not inconceivable. For example, 
there is a well described relationship between mutations in the glucokinase gene (GCK) and 
offspring birthweight, whereby if the mutation is present in the mother and not the offspring 
then birthweight is increased, whereas if the mutation is present in the offspring but not the 
mother then birthweight is decreased.(31) Given birthweight is a component of GWG, it is 
plausible that variants in GCK and other mutations involved in insulin secretion could 
produce similar effects on GWG. However, given the large standard error on the estimate, 
this negative covariance might be a chance finding and requires replication before any further 
interpretation is made. 
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Our lack of replicated genome-wide significant findings might be due to the complexity of 
the GWG phenotype. Weight was measured by trained personnel during pregnancy in the 
majority of studies included in this meta-analysis, however the pre-pregnancy measure was 
often self-report and the early pregnancy measure would have included some pregnancy 
weight gain. This would have increased the measurement error for GWG, making it difficult 
to identify true genetic associations. In addition, we had low statistical power to detect 
associations with genetic variants which have a small effect. With an alpha of 5x10
-8
 in the 
maternal GWAS of total GWG, we had 80% power to detect a genetic variant that explained 
between 0.37% and 0.4% of the variance for our range of sample sizes (N=9,832 – 10,543). 
Similarly, we had 80% power to detect a variant that explained 0.24% - 0.3% of the variance 
in the offspring GWAS of total GWG (N=12,995 – 16,317). However, for other complex 
quantitative phenotypes, such as BMI, the genetic variants discovered to date each explain 
0.003-0.325% of the variance,(32) indicating that many common genetic variants each of 
small effect influence the trait. Therefore, we had adequate power to detect common genetic 
variants with modest to large effects, but we were unable to detect variants with smaller 
effects, even though we used the largest sample of individuals for exploring genetic 
associations with this phenotype to date and are unaware currently of other European origin 
studies that could have added to this effort.  
 
Despite most of our analyses suggesting a stronger contribution of maternal, than fetal 
common genetic variants to GWG, the one nominally significant variant that replicated was 
for a fetal variant that was related to total GWG. This variant on chromosome 18, is near to 
the Synaptotagmin 4 (SYT4) gene, which is a protein coding gene involved in calcium and 
syntaxin binding.(33) Its relation to GWG is unclear and this association should be treated 
with caution unless further replicated, particularly as the association was only nominal and 
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did not reach conventional GWAS significance of 5×10
-8
 even in combined meta-analysis of 
discovery and replication samples (the result being per allele difference in mean total GWG: 
0.06 (95%CI: 0.04, 0.08) kg/week; p = 1.6×10
-5
 in pooled discovery and replication). 
 
There is little clear evidence linking most of the genes nearest our top 10 loci to GWG. 
However, some speculative evidence exists for the following nearest genes. The gene nearest 
our strongest association in the discovery GWAS was PSG5 (pregnancy-specific beta-1 
glycoprotein 5), which belongs to a group of molecules that are mainly produced during 
pregnancy by the placental syncytiotrophoblasts. Pregnancy-specific beta-1 glycoprotein 
(PSBG) levels have been correlated with placental function and fetal wellbeing(34). 
TMEM163, which harbours rs481396, is a putative zinc transporter(35). Zinc has been shown 
to be positively correlated with birthweight(36). Two of the genes nearest to the index SNPs 
taken forward for replication have previously been associated with adult height(37), LCORL 
and HLA-C. LCORL has also been associated with birthweight(38) and birth length(39) 
which might be driving the association with GWG. HLA-C, being part of the MHC has also 
been associated with various auto-immune diseases such as psoriasis, Crohn’s disease and 
atopic-dermatitis. Variants in TCERG1L have been shown to be associated with fasting 
insulin and insulin resistance in an African American population(40), which could have 
implications for growth of both the mother and the offspring. 
 
We expanded on previous studies that examined the associations of candidate maternal and/or 
fetal adiposity or diabetes related genetic variants with GWG(15-17) by looking at a wider 
variety of phenotypes that are observationally related to GWG (previous studies looked only 
at BMI and type 2 diabetes), in a considerably larger sample of participants and using a 
greater number of variants for each phenotype. We are aware that for some of the phenotypes 
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investigated, there are a larger number of associated SNPs in the more recent GWAS, for 
example over 90 variants have now been shown to independently relate to BMI.(32) The 
subset of variants that we used for each phenotype were those with the largest effect sizes on 
each of the individual traits and that were available in the majority of replication (as well as 
discovery) samples, therefore we will have greater power to detect an effect with GWG if one 
exists.  
 
The main strength of this study was the availability of both maternal and offspring genotype 
and the three separate phenotypes for GWG allowing us to investigate whether genetic 
variants had consistent effects throughout pregnancy. Our main analyses explored genetic 
contributions to total GWG. This enabled us to maximise our sample size, but it assumes that 
weight gain is linear across gestation. Evidence suggests that GWG is slower in early 
pregnancy up to 14 to 18 weeks depending on how it is measured and the population studied, 
but for the majority of pregnancy from this time point it is broadly linear.(1, 20) Furthermore, 
we examined associations (in smaller sub-sets) with early and late GWG. The choice of 18-
20 weeks to distinguish between early and late GWG was determined on the basis of 
maximising sample sizes, evidence for differences in fetal and maternal contributions before 
and after this time,(1, 19) and multilevel modelling in the ALSPAC cohort, which was the 
largest contributing cohort to our study with multiple repeated weight measures throughout 
pregnancy.(20) The weak correlation between early and late GWG in our largest cohort 
contributing to these measures, supports these two periods being relatively independent of 
each other. GWG varies by pre- or early-pregnancy BMI and other characteristics such as 
parity and ethnicity,(2) and some, but not all, studies suggest that associations of GWG with 
maternal and offspring outcomes varies by maternal BMI; the review that informed the 
Institute of Medicine recommendations for GWG noted that even for associations with 
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outcomes that appeared to vary by BMI these subgroup analyses could not be considered 
robust.(2) We were interested here in maternal and fetal genetic contributions to GWG in 
whole populations, and as with other studies of candidate genes with GWG, we have not 
looked at whether GWAS results would differ by maternal BMI. We would have limited 
power to do so and would be concerned about spurious subgroup findings from such 
analyses. We acknowledge that further analyses in studies that would enable more refined 
GWAS of trajectories of GWG across pregnancy, and with larger sample sizes that could 
explore possible interactions with maternal characteristics, such as BMI, ethnicity and parity, 
would be beneficial. However, our knowledge of the literature and potentially suitable studies 
suggests that currently only ALSPAC has detailed repeat measurements together with 
genome-wide data on mothers and offspring and it alone is too small to be adequately 
powered for such analyses. Furthermore, we have made every effort to engage with all 
cohorts that have both genetic and phenotypic data. Despite being the first large GWAS of 
this trait, to our knowledge and our effort to include all studies of European origin women 
with relevant data, we had limited power to detect variants with weak effects and will 
continue to seek additional studies to contribute to large GWAS in the future. 
 
In summary, we have identified that a substantial proportion of the variation in GWG can be 
explained by common variants in the maternal genome, with an additional smaller proportion 
being explained by the offspring genome. In what we believe to be the first GWAS of GWG, 
using the largest collection of individuals, we were unable to identify any loci with a large 
effect on GWG and that replicated, but found some evidence that maternal variants may 
contribute more to GWG than fetal variants. These initial results suggest that the association 
of GWG with later offspring outcome may reflect intrauterine (maternal) effects. However, 
given the composite nature of GWG, including increasing maternal fat stores and plasma 
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volume, the growing fetus, placenta and amniotic fluid, larger sample sizes are required to 
identify individual genetic loci for GWG. 
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Table 1: The most significant SNPs from each locus that reached P<10-5 from the discovery meta-analysis in all individuals. The nearest gene is used as the 
locus name. 
 Early GWG Late GWG Total GWG 
 Mat 
or 
Off 
Chr Position 
(bp) 
EA/
OA 
EAF
1 
N Beta
2 
SE P-Value N Beta
2 
 
SE P-Value N Beta
2 
SE P-Value 
rs481396 (TMEM163) 
Discovery Mat 2 134953875 T/C 0.72 7,704 0.059 0.018 9.1x10
-4
 7,681 0.062 0.018 4.1x10
-4
 10,537 0.068 0.015 6.8x10
-6
 
Replication Mat 2 134953875 T/C 0.68 1,575 0.003 0.039 0.93 1,637 -0.077 0.038 0.04 7,883 -0.021 0.017 0.21 
Discovery Off 2 134953875 T/C 0.70 8,552 0.034 0.017 0.05 8,623 0.030 0.017 0.08 15,642 0.027 0.013 0.03 
Replication Off 2 134953875 T/C 0.70 3,288 0.037 0.028 0.18 778 0.020 0.060 0.73 4,546 0.014 0.025 0.57 
rs3924699 (LCORL) 
Discovery Mat 4 18300153 G/C 0.10 7,704 0.101 0.028 3.6x10
-4
 7,681 0.109 0.028 1.1x10
-4
 10,543 0.106 0.024 9.0x10
-6
 
Replication Mat 4 18300153 G/C 0.11 1,570 0.041 0.059 0.49 1,633 0.003 0.057 0.96 7,321 0.031 0.027 0.25 
Discovery Off 4 18300153 G/C 0.10 8,552 0.054 0.027 0.04 8,624 0.074 0.027 5.5x10
-3
 15,636 0.042 0.021 0.05 
Replication Off 4 18300153 G/C 0.08 3,280 0.131 0.076 0.08 771 -0.017 0.139 0.90 4,380 0.023 0.041 0.58 
rs9995522 (UGDH) 
Discovery Mat 4 39179591 A/G 0.93 7,704 0.118 0.033 4.1x10
-4
 7,681 0.035 0.033 0.30 10,337 0.047 0.029 0.11 
Replication Mat 4 39179591 A/G 0.94 1,303 0.153 0.091 0.09 1,365 0.030 0.089 0.74 7,074 0.070 0.035 0.05 
Discovery Off 4 39179591 A/G 0.93 8,552 0.161 0.032 5.3x10
-7
 8,625 0.051 0.032 0.12 16,317 0.094 0.024 8.3x10
-5
 
Replication Off 4 39179591 A/G 0.94 3,284 -0.037 0.060 0.53 774 0.019 0.122 0.88 4,492 0.020 0.040 0.62 
rs6457375 (HLA-C) 
Discovery Mat 6 31380591 G/A 0.52 7,704 0.077 0.017 3.4x10
-6
 7,681 0.035 0.017 0.04 9,832 0.049 0.015 9.5x10
-4
 
Replication Mat 6 31380591 G/A 0.53 1,294 0.002 0.036 0.96 1,346 -0.035 0.036 0.33 6,976 -0.001 0.015 0.96 
Discovery Off 6 31380591 G/A 0.52 8,552 0.036 0.016 0.03 8,625 0.038 0.016 0.02 15,166 0.029 0.012 0.02 
Replication Off 6 31380591 G/A 0.51 3,209 -0.005 0.025 0.85 700 0.030 0.054 0.58 2,972 -0.007 0.024 0.76 
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 Early GWG Late GWG Total GWG 
 Mat 
or 
Off 
Chr Position 
(bp) 
EA/
OA 
EAF
1 
N Beta
2 
SE P-Value N Beta
2 
 
SE P-Value N Beta
2 
SE P-Value 
rs13295979 (ERCC6L2/HSD17B3) 
Discovery Mat 9 97879618 T/G 0.90 7,704 0.113 0.037 2.4x10
-3
 7,681 0.120 0.037 1.3x10
-3
 9,832 0.138 0.033 2.4x10
-5
 
Replication Mat 9 97879618 T/G 0.92 1,126 0.047 0.082 0.57 1,112 0.028 0.083 0.74 5,656 -0.004 0.035 0.91 
Discovery Off 9 97879618 T/G 0.90 8,552 0.082 0.035 0.02 8,623 0.073 0.035 0.04 15,166 0.078 0.027 3.3x10
-3
 
Replication Off 9 97879618 T/G 0.92 3,209 -0.031 0.046 0.50 700 -0.039 0.096 0.68 3,599 0.063 0.045 0.16 
rs1702200 (GLRX3/TCERG1L) 
Discovery Mat 10 132346882 G/T 0.50 7,704 0.035 0.017 0.03 7,681 0.060 0.017 2.9x10
-4
 10,475 0.064 0.014 6.6x10
-6
 
Replication Mat 10 132346882 G/T 0.50 1,576 -0.003 0.036 0.92 1,638 0.025 0.035 0.48 7,891 -0.024 0.016 0.14 
Discovery Off 10 132346882 G/T 0.50 8,552 -0.011 0.016 0.50 8,624 0.021 0.016 0.17 13,424 0.024 0.013 0.06 
Replication Off 10 132346882 G/T 0.50 3,287 0.009 0.025 0.70 777 0.081 0.051 0.12 4,527 0.014 0.022 0.54 
rs7133083 (RBM19) 
Discovery Mat 12 112942277 A/G 0.83 7,704 0.108 0.022 1.5x10
-6
 7,681 0.056 0.023 0.01 9,832 0.090 0.020 6.4x10
-6
 
Replication Mat 12 112942277 A/G 0.82 1,582 0.028 0.049 0.57 1,644 0.053 0.048 0.27 7,361 0.005 0.021 0.83 
Discovery Off 12 112942277 A/G 0.83 8,552 0.042 0.021 0.05 8,623 0.005 0.021 0.80 15,165 0.018 0.016 0.26 
Replication Off 12 112942277 A/G 0.84 3,208 -0.006 0.039 0.88 699 -0.030 0.087 0.73 3,637 0.040 0.033 0.23 
rs7301563 (NTF3) 
Discovery Mat 12 5436393 T/C 0.18 7,704 0.024 0.022 0.26 7,681 0.019 0.022 0.39 10,325 0.027 0.019 0.15 
Replication Mat 12 5436393 T/C 0.19 1,576 0.042 0.047 0.38 1,644 0.073 0.043 0.11 7,355 -0.001 0.021 0.97 
Discovery Off 12 5436393 T/C 0.18 8,552 0.088 0.019 4.9x10
-6
 8,625 0.035 0.019 0.07 15,163 0.041 0.015 6.5x10
-3
 
Replication Off 12 5436393 T/C 0.18 3,270 -0.060 0.032 0.06 760 -0.061 0.065 0.35 4,312 -0.005 0.029 0.87 
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 Early GWG Late GWG Total GWG 
 Mat 
or 
Off 
Chr Position 
(bp) 
EA/
OA 
EAF
1 
N Beta
2 
SE P-Value N Beta
2 
 
SE P-Value N Beta
2 
SE P-Value 
rs310087 (SYT4) 
Discovery Mat 18 39147836 A/G 0.49 7,704 0.013 0.017 0.42 7,681 0.023 0.017 0.17 9,832 0.016 0.015 0.26 
Replication Mat 18 39147836 A/G 0.47 1,581 -0.038 0.035 0.28 1,643 -0.002 0.035 0.95 7,357 0.009 0.017 0.59 
Discovery Off 18 39147836 A/G 0.48 8,552 0.041 0.016 7.8x10
-3
 8,623 0.055 0.016 4.6x10
-4
 12,995 0.060 0.013 3.0x10
-6
 
Replication Off 18 39147836 A/G 0.50 3,285 -0.004 0.025 0.87 775 -0.003 0.051 0.95 4,452 0.050 0.022 0.03 
rs16989175 (PSG5) 
Discovery Mat 19 48337381 G/C 0.76 7,704 0.068 0.020 5.3x10
-4
 7,681 0.011 0.020 0.58 10,445 0.047 0.017 5.3x10
-3
 
Replication Mat 19 48337381 G/C 0.77 1,577 -0.076 0.044 0.09 1,639 -0.056 0.043 0.20 10,660 0.011 0.016 0.47 
Discovery Off 19 48337381 G/C 0.76 8,552 0.046 0.019 0.02 8,624 0.058 0.019 2.4x10
-3
 15,568 0.079 0.014 1.7x10
-8
 
Replication Off 19 48337381 G/C 0.76 3,270 -0.040 0.028 0.15 760 -0.076 0.058 0.19 7,561 -0.005 0.019 0.78 
1 Average effect allele frequency (EAF) across the cohorts in the total GWG meta-analyses. 
2 Betas are the difference in mean gestational weight gain in kg per week of gestation per additional effect allele 
Mat: maternal genome; Off: Offspring (i.e. fetal genome) 
EA/OA: Effect allele / other allele 
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Table 2: Estimates (standard errors) of proportion of maternal and fetal genetic contributions from 
common variants to gestational weight gain  
 GREML Resultsa M-GCTA Results 
 Maternal 
genome 
N=6,435 
Child genome 
N=6,418 
Maternal 
genome 
N=4,078 
Child genome 
N=4,078 
Covariance 
N=4,078 
Early 0.195 (0.055) 0.058 (0.053)  0.021 (0.113) 0.000 (0.115) 0.067 (0.091) 
Late 0.244 (0.054)  0.110 (0.053) 0.196 (0.113) 0.161 (0.114) -0.039 (0.091) 
Total 0.239 (0.055)  0.121 (0.053)  0.173 (0.112) 0.045 (0.113) 0.016 (0.090) 
Birthweight 0.13 (0.06) 0.18 (0.06)  0.04 (0.10) 0.24 (0.11) 0.04 (0.08) 
a P-values for the GREML results are: Maternal genome, early GWG = 1.12x10-4, Maternal genome, 
late GWG = 8.83x10-7, Maternal genome, total GWG = 1.94x10-6, Maternal genome, birth weight = 
0.02, Offspring genome, early GWG = 0.130, Offspring genome, late GWG = 0.015, Offspring 
genome, total GWG = 0.008, Offspring genome, birth weight =  1.86x10-3 
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Table 3: Results from the unconditional analysis and analysis conditional on offspring (row 2 of each SNP) or maternal genotype (row 4 of each SNP) for the 
most significant SNPs from each locus that reached P<10-5 from the discovery meta-analysis; results from the maternal and offspring genotypes are 
presented. The nearest gene is used as the locus name. 
 Early GWG Late GWG Total GWG
1 
 Genome Chr Position 
(bp) 
EA/OA N Beta
1 
SE P-Value N Beta
1 
 
SE P-Value N Beta SE P-Value 
rs481396 (TMEM163) 
Unconditional Mat 2 134953875 T/C 6,635 0.040 0.019 0.03 6,674 0.057 0.019 2.3x10
-3
 12,844 0.036 0.013 7.0x10
-3
 
Conditional Mat 2 134953875 T/C 6,103 0.041 0.022 0.06 6,165 0.050 0.022 0.03 10,079 0.031 0.017 0.07 
Unconditional Off 2 134953875 T/C 6,291 0.040 0.019 0.04 6,356 0.031 0.019 0.11 11,340 0.033 0.015 0.03 
Conditional Off 2 134953875 T/C 6,103 0.012 0.022 0.59 6,165 0.011 0.023 0.64 10,079 0.019 0.018 0.28 
rs3924699 (LCORL) 
Unconditional Mat 4 18300153 G/C 6,630 0.068 0.030 0.02 6,670 0.075 0.030 0.01 12,830 0.055 0.021 7.6x10
-3
 
Conditional Mat 4 18300153 G/C 6,091 0.052 0.035 0.14 6,155 0.050 0.035 0.15 10,031 0.030 0.027 0.28 
Unconditional Off 4 18300153 G/C 6,283 0.050 0.030 0.09 6,350 0.074 0.030 0.01 11,241 0.047 0.023 0.05 
Conditional Off 4 18300153 G/C 6,091 0.025 0.035 0.47 6,155 0.045 0.035 0.20 10,031 0.027 0.028 0.33 
rs9995522 (UGDH) 
Unconditional Mat 4 39179591 A/G 6,638 0.113 0.035 1.5x10
-3
 6,677 -0.020 0.026 0.44 12,838 0.055 0.026 0.03 
Conditional Mat 4 39179591 A/G 6,101 0.041 0.042 0.34 6,163 0.039 0.043 0.36 10,057 0.037 0.033 0.26 
Unconditional Off 4 39179591 A/G 6,288 0.179 0.035 4.8x10
-7
 6,354 -0.007 0.036 0.84 11,289 0.070 0.026 6.4x10
-3
 
Conditional Off 4 39179591 A/G 6,101 0.163 0.041 8.2x10
-5
 6,163 -0.024 0.042 0.56 10,057 0.060 0.031 0.05 
rs6457375 (HLA-C) 
Unconditional Mat 6 31380591 G/A 5,474 0.057 0.019 3.1x10
-3
 5,446 0.009 0.020 0.64 9,530 0.020 0.014 0.16 
Conditional Mat 6 31380591 G/A 5,378 0.052 0.022 0.02 5,366 0.014 0.022 0.52 8,688 0.029 0.017 0.09 
Unconditional Off 6 31380591 G/A 5,480 0.023 0.020 0.233 5,458 0.020 0.007 0.74 9,388 0.005 0.015 0.71 
Conditional Off 6 31380591 G/A 5,378 -0.0005 0.022 0.98 5,366 -0.002 0.023 0.93 8,688 -0.011 0.017 0.53 
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 Early GWG Late GWG Total GWG
1 
 Genome Chr Position 
(bp) 
EA/OA N Beta
1 
SE P-Value N Beta
1 
 
SE P-Value N Beta SE P-Value 
rs13295979 (ERCC6L2/HSD17B3) 
Unconditional Mat 9 97879618 T/G 5,826 0.117 0.040 3.7x10
-3
 5,805 0.118 0.041 3.9x10
-3
 11,087 0.061 0.027 0.03 
Conditional Mat 9 97879618 T/G 5,577 0.086 0.046 0.06 5,564 0.105 0.047 0.02 9,367 0.055 0.034 0.10 
Unconditional Off 9 97879618 T/G 5,668 0.095 0.041 0.02 5,643 0.103 0.042 0.01 10,051 0.094 0.030 2.1x10
-3
 
Conditional Off 9 97879618 T/G 5,577 0.051 0.046 0.26 5,564 0.052 0.046 0.27 9,367 0.061 0.035 0.08 
rs1702200 (GLRX3/TCERG1L) 
Unconditional Mat 10 132346882 G/T 6,636 0.008 0.017 0.65 6,675 0.044 0.017 0.01 12,840 0.027 0.012 0.03 
Conditional Mat 10 132346882 G/T 6,105 0.003 0.021 0.90 6,167 0.054 0.021 0.01 10,082 0.032 0.016 0.05 
Unconditional Off 10 132346882 G/T 6,290 -0.011 0.018 0.54 6,356 0.022 0.018 0.23 11,328 0.021 0.014 0.13 
Conditional Off 10 132346882 G/T 6,105 0.001 0.021 0.97 6,167 -0.019 0.021 0.37 10,082 -0.001 0.016 0.97 
rs7133083 (RBM19) 
Unconditional Mat 12 112942277 A/G 5,834 0.099 0.025 5.3x10
-5
 5,812 0.042 0.025 0.09 11,147 0.040 0.017 0.02 
Conditional Mat 12 112942277 A/G 5,580 0.105 0.029 2.7x10
-4
 5,566 0.036 0.029 0.21 9,430 0.042 0.022 0.06 
Unconditional Off 12 112942277 A/G 5,667 0.033 0.025 0.20 5,642 0.026 0.025 0.31 10,089 0.038 0.019 0.05 
Conditional Off 12 112942277 A/G 5,580 -0.011 0.029 0.70 5,566 0.001 0.029 0.96 9,430 0.022 0.022 0.32 
rs7301563 (NTF3) 
Unconditional Mat 12 5436393 T/C 6,636 0.041 0.022 0.07 6,681 0.023 0.022 0.30 12,841 0.021 0.016 0.20 
Conditional Mat 12 5436393 T/C 6,084 -0.012 0.026 0.64 6,146 0.013 0.027 0.63 9,965 0.002 0.021 0.94 
Unconditional Off 12 5436393 T/C 6,274 0.105 0.022 3.2x10
-6
 6,340 0.028 0.023 0.22 11,100 0.064 0.018 3.3x10
-4
 
Conditional Off 12 5436393 T/C 6,084 0.089 0.026 7.5x10
-4
 6,146 0.044 0.027 0.10 9,965 0.071 0.021 8.7x10
-4
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 Early GWG Late GWG Total GWG
1 
 Genome Chr Position 
(bp) 
EA/OA N Beta
1 
SE P-Value N Beta
1 
 
SE P-Value N Beta SE P-Value 
rs310087 (SYT4) 
Unconditional Mat 18 39147836 A/G 6,641 0.012 0.017 0.49 6,680 0.020 0.017 0.24 12,848 0.016 0.012 0.18 
Conditional Mat 18 39147836 A/G 6,104 -0.009 0.020 0.66 6,166 -0.001 0.021 0.95 10,059 -0.014 0.016 0.39 
Unconditional Off 18 39147836 A/G 6,288 0.035 0.017 0.04 6,353 0.057 0.017 1.1x10
-3
 11,278 0.058 0.014 1.6x10
-5
 
Conditional Off 18 39147836 A/G 6,104 0.041 0.020 0.04 6,166 0.057 0.021 5.3x10
-3
 10,059 0.067 0.016 3.1x10
-5
 
rs16989175 (PSG5) 
Unconditional Mat 19 48337381 G/C 6,637 0.039 0.020 0.06 6,676 0.003 0.020 0.87 16,162 0.029 0.013 0.02 
Conditional Mat 19 48337381 G/C 6,085 0.026 0.034 0.28 6,147 -0.024 0.024 0.32 13,143 0.004 0.017 0.82 
Unconditional Off 19 48337381 G/C 6,273 0.057 0.021 7.4x10
-3
 6,339 0.049 0.021 0.02 14,363 0.058 0.014 3.7x10
-5
 
Conditional Off 19 48337381 G/C 6,085 0.042 0.024 0.08 6,147 0.050 0.025 0.04 13,143 0.055 0.017 9.6x10
-4
 
1 Betas are the difference in mean gestational weight gain in kg per week of gestation per additional effect allele 
Mat: maternal genome; Off: Offspring (i.e. fetal genome) 
EA/OA: Effect allele / other allele 
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